An Appeal to the Global Health Community for a Tripartite Innovation: An "essential Diagnostics List," "health in All Policies," and "see-Through 21st Century Science and Ethics"

OMICS A Journal of Integrative Biology

Volumn 19, Issue 8, 2015, Pages 435-442

  Dove, Edward S ^a   Barlas, Ömer ^b   Birch, Kean ^c   Boehme, Catharina ^d   Borda Rodriguez, Alexander ^e,f   Byne, William M ^g,al   Chaverneff, Florence ^h   Coşkun, Yavuz ⁱ   Dahl, Marja Liisa ^j   Dereli, Türkay ⁱ   Diwakar, Shyam ^k   Elbeyli, Levent ⁱ   Endrenyi, Laszlo ^l   Eroʇlu Kesim, Belgin ^m   Ferguson, Lynnette R ⁿ   Güngör, Klvanç ⁱ   Gürsoy, Ulvi ^o   Hekim, Nezih ^p   Huzair, Farah ^q   Kaushik, Kabeer ^r   Kickbusch, Ilona ^s   Klroʇlu, Olcay ^t   Kolker, Eugene ^u,v,w,x   Könönen, Eija ^o   Lin, Biaoyang ^y,z   Llerena, Adrian ^aa   Malhan, Faruk ^ab   Nair, Bipin ^k   Patrinos, George P ^ac   Sardaş, Semra ^ad   Sert, Özlem ^ae   Srivastava, Sanjeeva ^af   Steuten, Lotte M G ^v,ag   Toraman, Cengiz ⁱ   Vayena, Effy ^ah   Wang, Wei ^ai,aj   Warnich, Louise ^ak   Özdemir, Vural ^i,k,w,am   more..

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b MERSIN UNIVERSITY   (Turkey)

^c YORK UNIVERSITY   (Canada)

^d FOUNDATION FOR INNOVATIVE NEW DIAGNOSTICS   (Switzerland)

^e Prometeo Project   (Ecuador)

^f OPEN UNIVERSITY   (United Kingdom)

^g MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^h NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

ⁱ GAZIANTEP UNIVERSITY   (Turkey)

^j KAROLINSKA INSTITUTE   (Sweden)

^k AMRITA UNIVERSITY   (India)

^l UNIVERSITY OF TORONTO   (Canada)

^m SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

ⁿ UNIVERSITY OF AUCKLAND   (New Zealand)

^o UNIVERSITY OF TURKU   (Finland)

^p BEYKENT UNIVERSITY   (Turkey)

^q UNIVERSITY OF EDINBURGH   (United Kingdom)

^r Vainteya Films Pvt Ltd New Delhi   (India)

^s GRADUATE INSTITUTE OF INTERNATIONAL AND DEVELOPMENT STUDIES   (Switzerland)

^t CUKUROVA UNIVERSITY   (Turkey)

^u SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^v UNIVERSITY OF WASHINGTON   (United States)

^w Data Enabled Life Sciences Alliance International DELSA Global   (United States)

^x NORTHEASTERN UNIVERSITY   (United States)

^y UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^z ZHEJIANG UNIVERSITY   (China)

^aa UNIVERSITY OF EXTREMADURA   (Spain)

^ab Istanbul Design Foundation   (Turkey)

^ac UNIVERSITY OF PATRAS   (Greece)

^ad MARMARA UNIVERSITY   (Turkey)

^ae HACETTEPE UNIVERSITY   (Turkey)

^af INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

^ag PANAXEA B V   (Netherlands)

^ah UNIVERSITY OF ZURICH   (Switzerland)

^ai EDITH COWAN UNIVERSITY   (Australia)

^aj CAPITAL MEDICAL UNIVERSITY   (China)

^ak STELLENBOSCH UNIVERSITY   (South Africa)

^al VETERANS AFFAIRS MEDICAL CENTER   (United States)

^am Mary Ann Liebert   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC PROCEDURE; GENDER; HEALTH CARE POLICY; HUMAN; HUMAN RIGHTS; MATERNAL WELFARE; MEDICAL ETHICS; PHARMACOGENOMICS; POVERTY; PRIORITY JOURNAL; REVIEW; ATTITUDE TO HEALTH; ECONOMICS; EDUCATION; ETHICS; HEALTH; MOLECULAR DIAGNOSIS; ORGANIZATION; PHARMACOGENETICS; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH; SUPPLY AND DISTRIBUTION; TRENDS;

BIOLOGICAL MARKER;

BIOMARKERS; DIAGNOSTIC SERVICES; GLOBAL HEALTH; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; ORGANIZATIONAL INNOVATION; PHARMACOGENETICS; PUBLIC HEALTH;

EID: 84938384222     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2015.0075     Document Type: Review

References (38)

1. Aklillu E, Persson I, Bertilsson L, Johansson I, Rodrigues F, and Ingelman-Sundberg M. (1996). Frequent distribution of ultrarapid metabolizers of debrisoquine in an ethiopian population carrying duplicated and multiduplicated functional CYP2D6 alleles. J Pharmacol Exp Ther 278, 441-446.
2. Birch K, and Tyfield D. (2013). Theorizing the bioeconomy: Biovalue, biocapital, bioeconomics or.what? Science Technol Human Values 38, 299-327.
3. Birko S, Dove ES, and Özdemir V. (2015). A Delphi technology foresight study: Mapping social construction of scientific evidence on metagenomics tests for water safety. PLoS One 10, e0129706.
4. Callon M, Lascoumes P, Barthe Y, and Burchell G. (2011). Acting in an Uncertain World: An Essay on Technical Democracy. Cambridge, Massachusetts: The MIT Press.
5. Conde J, AND Artzi N. (2015) The next generation of smart gold nanobeacons: Nanotheranostics is ready for prime time. Nanomedicine (Lond) 10, 1535-1538.
6. Dandara C, Huzair F, Borda-Rodriguez A, Chirikure S, Okpechi I, Warnich L, and Masimirembwa C. (2014). H3Africa and the African life sciences ecosystem: Building sustainable innovation. OMICS 18, 733-739.
7. de Vries J, and Pepper M. (2012). Genomic sovereignty and the African promise: Mining the African genome for the benefit of Africa. J Med Ethics 38, 474-478.
8. Dove ES. (2013). Questioning the governance of pharmacogenomics and precision medicine for global health. Curr Pharmacogenom Person Med 11, 253-256. Available from: http://eurekaselect.com/118310. Accessed May 28, 2015.
9. Dove ES, and Özdemir V. (2013). 'Regular science' is inherently political. EMBO Rep 14, 113.
10. Dove ES, and Özdemir V. (2014). The epiknowledge of socially responsible innovation. EMBO Rep 15, 462-463.
11. Dove ES, Faraj SA, Kolker E, and Özdemir V. (2012). Designing a post-genomics knowledge ecosystem to translate pharmacogenomics into public health action. Genome Med 4, 91.
12. Dzau VJ, Ginsburg GS, Van Nuys K, Agus D, and Goldman D. (2015). Aligning incentives to fulfil the promise of personalised medicine. Lancet 385, 2118-2119.
13. [Editorial, No authors listed] (2013) What is the purpose of medical research? Lancet 381, 347.
14. ElRakaiby M, Dutilh BE, Rizkallah MR, Boleij A, Cole JN, and Aziz RK. (2014). Pharmacomicrobiomics: The impact of human microbiome variations on systems pharmacology and personalized therapeutics. OMICS 18, 402-414.
15. European Commission. (2007). EUR 22700-Science & Governance-Taking European Knowledge Society Seriously. Luxembourg: Office for Official Publications of the European Communities. Available at: http://ec.europa.eu/research/science-society/document-library/pdf-06/europeanknowledge-society-en.pdf. Accessed May 28, 2015.
16. Haffeld J, and Siem H. (2013). The post-2015 agenda: Complexity theory-based governance of the global health system in the era of postgenomics and personalized medicine. Curr Pharmacogenomics Person Med 11, 309-311.
17. Higdon R, Earl RK, Stanberry L, et al. (2015). The promise of multi-omics and clinical data integration to identify and target personalized healthcare approaches in autism spectrum disorders. OMICS 19, 197-208.
18. Hotez PJ. (2013). NTDs V.2.0: ''blue marble health''- Neglected tropical disease control and elimination in a shifting health policy landscape. PLoS Negl Trop Dis 7, e2570.
19. Kickbusch I. (2010). Health in all policies. Where to from here? Health Promot Intl 25, 261-264.
20. Mizzi C, Mitropoulou C, Mitropoulos K, et al. (2014). Personalized pharmacogenomics profiling using whole genome sequencing. Pharmacogenomics 15, 1223-1234.
21. Nowotny H. (2007). Putting the ''limits of science'' into context. ''Knowledge Production and its Constraints: epistemic and societal considerations'', Gulbenkian Foundation, Lisbon, October. Available from: http://www.helga-nowotny.eu/downloads/helga-nowotny-b58.pdf. Accessed May 28, 2015.
22. Ostrom E. (1990). Governing the Commons: The Evolution of Institutions for Collective Action. Cambridge, United Kingdom: Cambridge University Press.
23. Özdemir V. (2014). Personalized medicine across disciplines and without borders. Per Med 18, 687-691. Available from: http://www.futuremedicine.com/doi/pdf/10.2217/pme.14.70.Accessed May 28, 2015.
24. Özdemir V, and Lerer B. (2005). Pharmacogenomics and the promise of personalized medicine. In: Pharmacogenomics, Second Expanded Edition. Kalow W, Meyer UA, Tyndale RF (Editors), New York: Francis & Taylor, pp. 13-50.
25. Özdemir V, and Cho WC. (2012). Theranostics: Rethinking postgenomic diagnostics. Expert Rev Mol Diagn 12, 783-785.
26. Özdemir V, Gunes A, Dahl ML, Scordo MG, Williams-Jones B, and Someya T. (2006). Could endogenous substrates of drug-metabolizing enzymes influence constitutive physiology and drug target responsiveness? Pharmacogenomics 7, 1199-1210.
27. Özdemir V, Borda-Rodriguez A, Dove ES, et al. (2013). Public health pharmacogenomics and the design principles for global public goods-Moving genomics to responsible innovation. Curr Pharmacogenomics Person Med 11, 1-14.
28. Özdemir V, Klç H,Yldrm A, et al. (2015a). A code of ethics for ethicists: What would Pierre Bourdieu say? ''Do Not Misuse Social Capital in the Age of Consortia Ethics''. Am J Bioethics 15, 64-67.
29. Özdemir V, Faris J, and Srivastava S. (2015b). Crowdfunding 2.0: The next-generation philanthropy: A new approach for philanthropists and citizens to co-fund disruptive innovation in global health. EMBO Rep 16, 267-271.
30. Özdemir V. (2015). New biology and United Nations Sustainable Development Goals (SDGs) 2016-2030: Values steering the OMICS: A Journal of Integrative Biology editorial flight deck. OMICS 19, 368-370.
31. Sxardas x S, Endrenyi L, Gürsoy UK, et al. (2014). A call for pharmacogenovigilance and rapid falsification in the age of big data: Why not first road test your biomarker? OMICS 18, 663-665.
32. Tasioulas J, and Vayena E. (2015). Getting human rights right in global health policy. Lancet 385, e42-44.
33. Tutton R. (2012). Personalizing medicine: Futures present and past. Soc Sci Med 75, 1721-1728.
34. World Health Organization. (2013). Essential medicines. Available from: http://www.who.int/medicines/services/essmedicines-Def/en/. Accessed May 28, 2015.
35. World Health Organization. (2015). WHO moves to improve access to lifesaving medicines for hepatitis C, drug-resistant TB and cancers. Available from: http://www.who.int/mediacentre/news/releases/2015/new-essential-medicines-list/en/. Accessed May 28, 2015.
36. World Economic Forum. (2015). The Gender Parity Programme. Available from: http://www.weforum.org/womenleaders-And-gender-parity. Accessed on May 28, 2015.
37. Yearley S. (2004). Making Sense of Science: Understanding the Social Study of Science. London: Sage.
38. Zhao F, Chen Y, Ge S, et al. (2014). A quantitative analysis of the mass media coverage of genomics medicine in China: A call for science journalism in the developing world. OMICS 18, 222-230.